Randomized phase I trial of antigen-specific tolerizing immunotherapy with peptide/calcitriol liposomes in ACPA(+) rheumatoid arthritis

BACKGROUND: Antigen-specific regulation of autoimmune disease is a major goal. In seropositive rheumatoid arthritis (RA), T cell help to autoreactive B cells matures the citrullinated (Cit) antigen-specific immune response, generating RA-specific V domain glycosylated anti-Cit protein antibodies (AC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonigra, Amee, Nel, Hendrik J., Wehr, Pascale, Ramnoruth, Nishta, Patel, Swati, van Schie, Karin A., Bladen, Maxwell W., Mehdi, Ahmed M., Tesiram, Joanne, Talekar, Meghna, Rossjohn, Jamie, Reid, Hugh H., Stuurman, Frederik E., Roberts, Helen, Vecchio, Phillip, Gourley, Ian, Rigby, Mark, Becart, Stephane, Toes, Rene E.M., Scherer, Hans Ulrich, Lê Cao, Kim-Anh, Campbell, Kim, Thomas, Ranjeny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2022
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714780/
https://www.ncbi.nlm.nih.gov/pubmed/36278483
http://dx.doi.org/10.1172/jci.insight.160964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714780/
https://www.ncbi.nlm.nih.gov/pubmed/36278483
http://dx.doi.org/10.1172/jci.insight.160964

Ejemplares similares